Ironwood Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US46333X1081

SecurityIRWD / Ironwood Pharmaceuticals, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in IRWD / Ironwood Pharmaceuticals, Inc.

On August 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 332,810 shares of Ironwood Pharmaceuticals, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -100.00 0
2025-05-15 2025-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 332,810 44,339 15.37 489 -61.71 0.0011
2025-02-14 2024-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 288,471 288,471 1,278 0.0039
2024-11-14 2024-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -28,168 -100.00 0 -100.00
2025-02-25 2024-06-30 13F/A-1 IRONWOOD PHARMACEUTICALS COM CL A 46333X108 28,168 -3,258 -10.37 184 -32.97 0.0005
2024-08-14 2024-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 28,168 -3,258 184 0.0005
2024-05-15 2024-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 31,426 -75,417 -70.59 274 -77.66 0.0008
2024-07-16 2023-12-31 13F/A-1 IRONWOOD PHARMACEUTICALS COM CL A 46333X108 106,843 80,043 298.67 1,222 373.64 0.0039
2024-02-14 2023-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 106,843 80,043 1,222 0.0024
2023-11-14 2023-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 26,800 -5,000 -15.72 258 -23.67 0.0009
2023-08-14 2023-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 31,800 9,900 45.21 338 46.96 0.0011
2023-05-15 2023-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 21,900 21,900 230 0.0008
2022-02-14 2021-12-31 13F Ironwood Pharmaceuticals COM CL A 46333X108 0 -77,400 -100.00 0 -100.00
2021-11-15 2021-09-30 13F Ironwood Pharmaceuticals COM CL A 46333X108 77,400 -355,500 -82.12 1,011 -81.85 0.0028
2021-08-13 2021-06-30 13F/A-1 Ironwood Pharmaceuticals COM CL A 46333X108 432,900 432,900 5,571 0.0157
2021-08-13 2021-06-30 13F Ironwood Pharmaceuticals COM CL A 46333X108 432,900 432,900 5,571 0.0094
2016-05-13 2016-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 0 -431,420 -100.00 0 -100.00
2016-02-12 2015-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 431,420 -3,712 -0.85 5,000 10.28 0.0218
2015-11-13 2015-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 435,132 11,847 2.80 4,534 -11.19 0.0186
2015-08-13 2015-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 423,285 4,661 1.11 5,105 -23.78 0.0204
2015-05-13 2015-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 418,624 -48,259 -10.34 6,698 -6.36 0.0276
2015-02-13 2014-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 466,883 -251,107 -34.97 7,153 -23.10 0.0287
2014-11-13 2014-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 717,990 7,062 0.99 9,302 -14.65 0.0398
2014-08-13 2014-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 710,928 -19,316 -2.65 10,899 21.14 0.0453
2014-05-13 2014-03-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 730,244 113,858 18.47 8,997 25.73 0.0391
2014-02-13 2013-12-31 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 616,386 21,420 3.60 7,156 1.50 0.0320
2013-11-13 2013-09-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 594,966 130,508 28.10 7,050 52.56 0.0347
2013-08-12 2013-06-30 13F IRONWOOD PHARMACEUTICALS COM CL A 46333X108 464,458 464,458 4,621 0.0245
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.